BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated

Kesorn Angchagun1, Phumrapee Boonklang1, Chalita Chomkatekaew1

  • 1Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Salaya, Nakhon Pathom, 10400, Thailand.

Wellcome Open Research
|November 6, 2023
PubMed
Abstract

Insights

Genetic factors in Burkholderia pseudomallei and hosts may influence melioidosis outcomes. The BurkHostGEN study investigates these genetic links in Thailand to understand disease acquisition and severity.

Area of Science:

  • Infectious Diseases
  • Genetics
  • Microbiology

Background:

  • Melioidosis, a fatal disease caused by Burkholderia pseudomallei, is common in Thailand, especially among farmers.
  • Exposure to contaminated soil and water increases risk, but disease outcomes vary.
  • Genetic factors in the bacterium, host, or both may influence melioidosis development and severity.

Purpose of the Study:

  • To investigate the role of genetic factors in melioidosis susceptibility and severity.
  • To identify host and bacterial genetic determinants of melioidosis.
  • To explore the genetic basis of diverse melioidosis infection outcomes.

Main Methods:

  • The BurkHostGEN study collects blood and household water samples from melioidosis patients and controls in Thailand.
  • Host DNA and RNA are analyzed, alongside bacterial DNA from B. pseudomallei isolates.
  • Metagenomic analysis of household water investigates environmental B. pseudomallei presence.

Main Results:

  • This study aims to identify specific B. pseudomallei and host genetic factors linked to melioidosis.
  • Analysis will correlate genetic data with disease acquisition and severity.
  • Data will be deposited in the European Genome-Phenome Archive (EGA) and European Nucleotide Archive (ENA).

Conclusions:

  • BurkHostGEN can uncover bacterial and host genetic factors influencing melioidosis.
  • Findings may elucidate melioidosis pathogenesis and disease severity.
  • The study supports research into other infectious diseases and biomarker validation.